Hiv 1 Resistance To C1836231
A genetic trait that provides resistance to HIV-1 infection. Rare in the general population. Not a condition requiring treatment itself.
Key facts at a glance
- ICD-10
- R69
- ICD-11
- MA00.0
- Body system
- immunologic
- Severity
- mild
- Chronic
- true
Signs and symptoms
Common signs and symptoms that may indicate this condition.
Generalized symptoms
(immunologic)Mild symptoms that may not significantly impact daily life.
Frequency: Common at all stages
Recurrent respiratory infections
(immunologic)Persistent lymphadenopathy
(immunologic)Unexplained fevers
(immunologic)Mild chronic fatigue
(immunologic)Diagnosis and tests
How this condition is diagnosed and what test results mean.
Initial screening tests
Standard diagnostic workup
Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]
Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]
Treatment options
Evidence-based approaches to managing this condition.
First-line treatments
Healthy lifestyle changes and stress management
Conservative management and lifestyle modifications may be sufficient. Monitor symptoms.
HIV drug resistance testing
Laboratory analysis of viral genetic material to identify specific antiretroviral resistance mutations and guide regimen selection.
Alternative antiretroviral regimen
Customized combination therapy selected based on resistance profile, typically involving newer agents with activity against resistant virus strains.
Additional treatment options
Viral load and CD4 monitoring
Frequent laboratory assessment to evaluate treatment efficacy and detect virologic failure requiring regimen adjustment.
monitoringMedication adherence support
Intensive counseling and support services to maximize adherence to complex multi-drug regimens essential for treatment success.
medicationNutritional support
Optimized nutrition and supplementation to support immune function and manage side effects of antiretroviral therapy.
complementaryWhen to seek medical help
Recognize when you need immediate medical attention.
Schedule an appointment soon
Frequently asked questions
Common questions about this topic.
What is Hiv 1 Resistance To C1836231?
Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]
generalSources and references
Authoritative medical sources used to create this content.
Saag MS, Benson CA, Gandhi RT, et al. Antiretroviral Drugs for Treatment and Prevention of HIV-1 Infection in Adults: Recommendations of the International Antiviral Society-USA Panel. JAMA. 2018.
Clutter DS, Jordan MR, Bertagnolio S, Shafer RW. HIV-1 Drug Resistance and Resistance Testing. Infect Dis Clin North Am. 2016.
Llibre JM, Cozzi-Lepri A, Pedersen C, et al. Evolution of Primary HIV Drug Resistance in a Virally Suppressed Population. Clin Infect Dis. 2021.
Rhee SY, Blanco JL, Jordan MR, et al. Geographic and Temporal Trends in the Molecular Epidemiology of HIV-1 Transmission. J Infect Dis. 2015.
Medication Comparisons
Compare medications used to treat Hiv 1 Resistance To C1836231. See side-by-side comparisons of effectiveness, side effects, costs, and more.
View Medication ComparisonsThis information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy